You're viewing a free preview.You're viewing a free preview — a sample of each dataset.
Companies
The longevity company universe by segment, stage, geography and capital raised.
657 companies tracked
| Company | Focus area | Funding |
|---|---|---|
| Yuvan Research | Rejuvenation & Regenerative Medicine | — |
| NRG Therapeutics | Mitochondrial Health | $98M |
| Mabwell | General Longevity Therapeutics | — |
| Amprion | Diagnostics & Biomarkers | — |
| HCW Biologics | Senolytics & Damage Clearance | $25M |
| Annovis Bio | Neurodegeneration & CNS | $31.7M |
| LifespanningRx | Longevity Clinics | — |
| Alterity Therapeutics | Neurodegeneration & CNS | $48M |
| Yuva Biosciences | Mitochondrial Health | $13.8M |
| Resolution Therapeutics | Rejuvenation & Regenerative Medicine | $134M |
Showing 10 of 657 companies
7-day free trial · already have an account?
Peek at other modules
News Feed
Curated longevity industry headlines with AI summaries, updated continuously.
Funding Tracker
Every disclosed longevity round — size, stage and the investors behind it.
Clinical Trials
Longevity-relevant trials by phase, sponsor, status and indication.
People & Movers
Who is joining, leaving and founding across the longevity sector.
Research
Peer-reviewed aging research distilled into investor-relevant takeaways.
Regulatory
FDA, EMA and policy developments that move the longevity market.